Bridge Diagnostics: Subchapter V Plan Confirmed by Cramdown
ElevenFlo ·
Bridge Diagnostics is administering its confirmed Subchapter V plan while pursuing receivables and reviewing claims. The court scheduled a post-confirmation status conference for December 16, 2026, with a status report due 14 days beforehand, under its continuance order Dkt. 300.
Jump to section
Bridge Diagnostics, LLC, a Southern California clinical diagnostics laboratory founded in 2020, filed a Subchapter V chapter 11 case bkdata.com: Bridge Diagnostic, LLC Files for Bankruptcy (BKData, 2024-03-29) (outside source) in the U.S. Bankruptcy Court for the Central District of California on March 29, 2024 (Santa Ana division). Bankruptcy filings describe a company that scaled rapidly during COVID testing and then faced a post-pandemic revenue decline tied to coverage changes affecting a PCR-based UTI testing line and unpaid COVID-related receivables. Filings also describe workforce reductions and a strategic pivot toward pharmacogenomic testing. The court approved postpetition financing of up to $800,000 secured by a priming lien on substantially all assets and the court entered a Confirmation Order Dkt. 203 approving a second amended plan in September 2024.
| Debtor | Bridge Diagnostics, LLC |
| Court | U.S. Bankruptcy Court, Central District of California (Santa Ana Division) |
| Case Number | 8:24-bk-10803 |
| Judge | Hon. Theodor C. Albert |
| Petition Date | March 29, 2024 |
| Restructuring Path | Subchapter V chapter 11 plan of reorganization |
| Confirmation Date | September 2024 |
| Postpetition Financing | Up to $800,000 postpetition loan with priming lien; maturity December 31, 2026 |
Table: Case Snapshot
Subchapter V Reorganization of a Clinical Diagnostics Laboratory
Facility. Bridge Diagnostics operated as a clinical medical laboratory in Irvine/Aliso Viejo, California. A facility design profile from LPA Design Studios describes a purpose-built diagnostics facility totaling 24,000 square feet lpadesignstudios.com: Bridge Diagnostics Facility Design (LPA Design Studios, 2021) (outside source), including 14,000 square feet of lab space and 10,000 square feet of office space, built as an expansion from a prior 6,500 square foot facility.
An NPI profile lists Bridge Diagnostics LLC as a "Clinical Medical Laboratory" with an NPI assigned in May 2020 npiprofile.com: Bridge Diagnostics NPI Profile (NPI Profile, 2020) (outside source) and identifies Jason Hansen as the authorized official. A CLIA listing describes an independent lab certificate of accreditation for nonwaived testing labprospects.com: Bridge Diagnostics CLIA Certification (LabProspects, 2024) (outside source) under CLIA number 05D2184382.
| Item | Publicly described details |
|---|---|
| Facility size | 24,000 sq. ft. total; 14,000 lab; 10,000 office |
| NPI | 1881215622 (Clinical Medical Laboratory) |
| CLIA | 05D2184382 (Certificate of Accreditation; nonwaived testing) |
Table: Operations snapshot (public records)
One growth database estimated revenue of $10.8 million and 50 employees growjo.com: Bridge Diagnostics Revenue and Employee Data (Growjo, 2024) (outside source) (down from 97 the prior year). Other directories list wider ranges (e.g., 51–200 or 100–200 employees linkedin.com: Bridge Diagnostics LinkedIn Company Profile (LinkedIn, 2024) (outside source)) and describe the company as operating in hospitals and healthcare or diagnostic testing signalhire.com: Bridge Diagnostics Company Overview (SignalHire, 2024) (outside source).
A BBB profile for Bridge Diagnostics lists a company start date of April 1, 2020, a location in Irvine, and a B- rating bbb.org: Bridge Diagnostics LLC Business Profile (Better Business Bureau, 2023-11-06) (outside source), stating that the company was not accredited and that one complaint had been filed without a response.
Distress drivers. Bankruptcy filings describe the company as scaling rapidly during COVID testing and then pivoting back toward pre-pandemic testing lines. The filings describe a revenue decline tied to coverage changes affecting a PCR-based UTI testing product line and unpaid COVID-related receivables. The filings also describe workforce reductions and a strategic shift toward pharmacogenomic testing.
The LinkedIn profile describes a focus on pharmacogenomics and "precision medicine data," linkedin.com: Bridge Diagnostics LinkedIn Company Profile (LinkedIn, 2024) (outside source) framing the company's aim as bridging diagnostics and therapeutics. A company directory similarly describes infectious diseases and women's health signalhire.com: Bridge Diagnostics Company Overview (SignalHire, 2024) (outside source) alongside pharmacogenomics.
Cash collateral. Early in the case, the debtor filed a Cash Collateral Motion Dkt. 22. Bridge subsequently sought additional postpetition financing rather than relying solely on cash collateral arrangements.
Postpetition financing. The Postpetition Loan Motion Dkt. 52 describes a loan facility of up to $800,000, with interim approval for $100,000, priced at 5% interest per annum compounded annually, and maturing on December 31, 2026. The filings describe the loan as being secured by a priming first-priority lien on substantially all assets (excluding avoidance actions).
| Term | Reported financing terms |
|---|---|
| Maximum borrowing | $800,000 total (interim approval for $100,000) |
| Interest | 5% per annum, compounded annually |
| Maturity | December 31, 2026 |
| Collateral | priming first-priority lien on substantially all assets (excluding avoidance actions) |
Table: Postpetition loan terms (high level)
Plan structure. Bridge filed multiple iterations of a chapter 11 plan and ultimately proceeded on a Second Amended Plan Dkt. 200 confirmed in September 2024. The plan included a granular secured creditor matrix (Class 1(a) through 1(m)), a dedicated insurer-related class (Class 2 for Blue Cross of California and Anthem Blue Cross Life), and a general unsecured class (Class 3). A portion of a secured claim held by "Hansen" was recharacterized into general unsecured treatment, and certain equipment collateral was surrendered to BayCap, with any deficiency treated as general unsecured claims.
| Class (high level) | Constituency | Treatment concepts described |
|---|---|---|
| Class 1(a)–1(m) | Secured creditors | Individualized treatment by creditor/collateral package |
| Class 2 | Blue Cross of California; Anthem Blue Cross Life | Insurer-related claims grouped into a dedicated class |
| Class 3 | General unsecured | Receives unsecured distributions; absorbs certain recharacterized and deficiency amounts |
Table: Plan class structure (high level)
Key professionals. A bankruptcy database listing identifies debtor counsel as Marshack Hays Wood LLP bkdata.com: Bridge Diagnostic, LLC Files for Bankruptcy (BKData, 2024-03-29) (outside source) (David Wood, counsel of record). Public profiles identify Jason Hansen as founder and CEO, with prior experience founding Precision Diagnostics theorg.com: Jason Hansen - Founder/CEO (The Org, 2024) (outside source) (founded in 2011) before founding Bridge Diagnostics in April 2020.
| Role | Publicly identified name / firm |
|---|---|
| Debtor counsel | Marshack Hays Wood LLP (David Wood) |
| CEO / founder | Jason Hansen |
Table: Key people (public sources)
Timeline. Bridge filed in late March 2024, moved through early liquidity motions in April, filed an initial plan in late June, amended the plan in August, and reached confirmation in September.
| Date | Case milestone (high level) |
|---|---|
| March 29, 2024 | chapter 11 Subchapter V petition filed |
| April 2024 | cash collateral motion filed |
| April 2024 | postpetition loan motion filed |
| June 24, 2024 | initial chapter 11 plan Dkt. 122 filed |
| August 6, 2024 | first amended plan filed |
| September 2024 | second amended plan filed and confirmed |
Table: Case timeline (selected)
Frequently Asked Questions
When did Bridge Diagnostics file chapter 11, and was it a Subchapter V case? Bridge Diagnostics filed chapter 11 on March 29, 2024 bkdata.com: Bridge Diagnostic, LLC Files for Bankruptcy (BKData, 2024-03-29) (outside source) in the Central District of California, and the case has been described as a chapter 11 Subchapter V filing.
Where was the case filed and what is the case number? The case is pending in the U.S. Bankruptcy Court for the Central District of California (Santa Ana division) under Case No. 8:24-bk-10803-TA bkdata.com: Bridge Diagnostic, LLC Files for Bankruptcy (BKData, 2024-03-29) (outside source).
What business did Bridge Diagnostics operate? Bridge Diagnostics operated as a clinical diagnostics laboratory in the Irvine/Aliso Viejo area. Public records identify it as a clinical medical laboratory with an NPI assigned in 2020 npiprofile.com: Bridge Diagnostics NPI Profile (NPI Profile, 2020) (outside source) and as a CLIA-accredited independent lab performing nonwaived testing labprospects.com: Bridge Diagnostics CLIA Certification (LabProspects, 2024) (outside source).
What facility footprint did the company operate? A facility design profile described a 24,000 square foot diagnostics facility lpadesignstudios.com: Bridge Diagnostics Facility Design (LPA Design Studios, 2021) (outside source) with 14,000 square feet of lab space and 10,000 square feet of office space.
What factors did bankruptcy filings describe as driving distress? Bankruptcy filings described a post-COVID revenue decline tied to testing mix changes, coverage changes affecting a PCR-based UTI testing line, unpaid COVID-related receivables, workforce reductions, and a pivot toward pharmacogenomic testing.
Did the debtor obtain postpetition financing and what were the key terms? Bankruptcy filings describe approval of a postpetition loan of up to $800,000 (with interim approval for $100,000), priced at 5% interest compounded annually, maturing December 31, 2026, and secured by a priming lien on substantially all assets (excluding avoidance actions).
How did the confirmed plan classify and treat secured creditors and general unsecured claims? The confirmed plan used multiple secured creditor classes (Class 1(a)–1(m)), a separate insurer-related class for Blue Cross of California and Anthem Blue Cross Life, and a general unsecured class. Filings describe treatment that included recharacterizing part of one secured claim into unsecured treatment and surrendering certain equipment to a secured creditor with any deficiency treated as unsecured.
When was the plan confirmed? The Confirmation Order was entered in September 2024, reflecting plan confirmation under the Subchapter V chapter 11 framework.
For more chapter 11 case coverage, visit the ElevenFlo bankruptcy blog.
Sources
- Dkt. 22Motion to Use Cash Collateral Debtor's Expedited Motion for Order Authorizing Use of Cash Collateral to Confirm That Its Secured Creditor is Adequately Protected; Memorandum of Points and Authorities; and Declarations of Edward Bidanset and Jason Hansen in Support; with Proof of Service [Hrg. 4/11/2024 at 10:00 a.m.] Filed by Debtor Bridge Diagnostic, LLC (Wood, David) (Entered: 04/08/2024)Filed Apr 8, 2024Apr 8, 2024
- Dkt. 52Emergency motion Debtor's Emergency Motion for Order Authorizing Debtor to Obtain Post-Petition Loan; and Request for Expedited Hearing with Proof of Service Filed by Debtor Bridge Diagnostic, LLC (Wood, David) (Entered: 04/23/2024)Filed Apr 23, 2024Apr 23, 2024
- Dkt. 122Chapter 11 Plan of Reorganization with Proof of Service Filed by Debtor Bridge Diagnostic, LLC (RE: related document(s)1 Chapter 11 Subchapter V Voluntary Petition Non-Individual. Fee Amount $1738 Filed by Bridge Diagnostic, LLC Chapter 11 Plan Subchapter V Due by 06/27/2024.Appointment of health care ombudsman due by 04/29/2024 (Wood, David) See docket entry no 2 for correction. Case's deficient List of Equity Security Holders due 4/12/2024. Summary of Assets and Liabilities (Form 106Sum or 206Sum) due 4/12/2024. Schedule A/B: Property (Form 106A/B or 206A/B) due 4/12/2024. Schedule D: Creditors Who Have Claims Secured by Property (Form 106D or 206D) due 4/12/2024. Schedule E/F: Creditors Who Have Unsecured Claims (Form 106E/F or 206E/F) due 4/12/2024. Schedule G: Executory Contracts and Unexpired Leases (Form 106G or 206G) due 4/12/2024. Schedule H: Your Codebtors (Form 106H or 206H) due 4/12/2024. Declaration Under Penalty of Perjury for Non-Individual Debtors (Form 202) due 4/12/2024. Statement of Financial Affairs (Form 107 or 207) due 4/12/2024. Incomplete Filings due by 4/12/2024.Corporate Resolution Authorizing Filing of Petition due 4/12/2024. Corporate Ownership Statement (LBR Form F1007-4) due by 4/12/2024. Statement of Related Cases (LBR Form F1015-2) due 4/12/2024. Disclosure of Compensation of Attorney for Debtor (Form 2030) due 4/12/2024. Verification of Master Mailing List of Creditors (LBR Form F1007-1) due 4/12/2024. Modified on 4/1/2024 (VN).). (Wood, David) (Entered: 06/24/2024)Filed Jun 24, 2024Jun 24, 2024
- Dkt. 200Amended Chapter 11 Plan Debtor's Second Amended Chapter 11 Plan of Reorganization Dated August 19, 2024 - REDLINED VERSION with Proof of Service Filed by Debtor Bridge Diagnostic, LLC (RE: related document(s)163 Amended Chapter 11 Plan Debtor's First Amended Chapter 11 Plan of Reorganization Dated August 6, 2024 with Proof of Service Filed by Debtor Bridge Diagnostic, LLC (RE: related document(s)122 Chapter 11 Plan of Reorganization with Proof of Service Filed by Debtor Bridge Diagnostic, LLC (RE: related document(s)1 Chapter 11 Subchapter V Voluntary Petition Non-Individual. Fee Amount $1738 Filed by Bridge Diagnostic, LLC Chapter 11 Plan Subchapter V Due by 06/27/2024.Appointment of health care ombudsman due by 04/29/2024 (Wood, David) See docket entry no 2 for correction. Case's deficient List of Equity Security Holders due 4/12/2024. Summary of Assets and Liabilities (Form 106Sum or 206Sum) due 4/12/2024. Schedule A/B: Property (Form 106A/B or 206A/B) due 4/12/2024. Schedule D: Creditors Who Have Claims Secured by Property (Form 106D or 206D) due 4/12/2024. Schedule E/F: Creditors Who Have Unsecured Claims (Form 106E/F or 206E/F) due 4/12/2024. Schedule G: Executory Contracts and Unexpired Leases (Form 106G or 206G) due 4/12/2024. Schedule H: Your Codebtors (Form 106H or 206H) due 4/12/2024. Declaration Under Penalty of Perjury for Non-Individual Debtors (Form 202) due 4/12/2024. Statement of Financial Affairs (Form 107 or 207) due 4/12/2024. Incomplete Filings due by 4/12/2024.Corporate Resolution Authorizing Filing of Petition due 4/12/2024. Corporate Ownership Statement (LBR Form F1007-4) due by 4/12/2024. Statement of Related Cases (LBR Form F1015-2) due 4/12/2024. Disclosure of Compensation of Attorney for Debtor (Form 2030) due 4/12/2024. Verification of Master Mailing List of Creditors (LBR Form F1007-1) due 4/12/2024. Modified on 4/1/2024 (VN).).).). (Wood, David) (Entered: 09/10/2024)Filed Sep 10, 2024Sep 10, 2024
- Dkt. 203Order Confirming Debtor's Second Amended Chapter 11 Plan Of Reorganization Dated August 19, 2024 (BNC-PDF) (Related Doc # 201 ) - IT IS HEREBY ORDERED THAT: 1. The Plan filed on September 10, 2024, as Dk. No. 201, with the non-material modifications states on the record at the August 14, 2024 - A post-confirmation staus conference will be held on February 12, 2025 at 10:00 a.m. - Please See Order For Further Ruling - Signed on 9/13/2024 (GD) (Entered: 09/13/2024)Filed Sep 13, 2024Sep 13, 2024
- Dkt. 300Post-Confirmation Conference ContinuedFiled Jun 8, 2026Jun 8, 2026
- WebBridge Diagnostic, LLC Files for Bankruptcy (BKData, 2024-03-29)bkdata.com · Outside source
- WebBridge Diagnostics Facility Design (LPA Design Studios, 2021)lpadesignstudios.com · Outside source
- WebBridge Diagnostics NPI Profile (NPI Profile, 2020)npiprofile.com · Outside source
- WebBridge Diagnostics CLIA Certification (LabProspects, 2024)labprospects.com · Outside source
- WebBridge Diagnostics Revenue and Employee Data (Growjo, 2024)growjo.com · Outside source
- WebBridge Diagnostics LinkedIn Company Profile (LinkedIn, 2024)linkedin.com · Outside source
- WebBridge Diagnostics Company Overview (SignalHire, 2024)signalhire.com · Outside source
- WebBridge Diagnostics LLC Business Profile (Better Business Bureau, 2023-11-06)bbb.org · Outside source
- WebJason Hansen - Founder/CEO (The Org, 2024)theorg.com · Outside source